Literature DB >> 16107771

Mast cell ion channels.

Peter Bradding1.   

Abstract

IgE-dependent activation of human mast cells is a central feature of allergy. However, alternative non-IgE-mediated signals derived from the complex inflammatory milieu are also important in driving chronic mast cell activation in many tissues. Irrespective of the point from where pathological secretion is sustained, all mechanisms will change the activity of the final 'effector' ion channels involved in normal stimulus-secretion coupling. IgE-dependent activation of human mast cells is characterised by an influx of extracellular Ca2+, which is essential for subsequent release of both preformed (granule-derived) mediators and newly generated autacoids and cytokines. In addition, flow of ions such as K+ and Cl- are likely to play an important role in mast cell activation through their effect on cell membrane potential and thus Ca2+ influx. Emerging evidence suggests that mast cells express a number of channels carrying K+, Cl- and Ca2+. With current techniques it will be possible to identify the molecular origin of these channels and define precisely their role in mast cell function. Mast cell ion channels offer a novel target for the attenuation of allergic disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16107771     DOI: 10.1159/000087643

Source DB:  PubMed          Journal:  Chem Immunol Allergy        ISSN: 0079-6034


  14 in total

1.  Functional KCa3.1 K+ channels are required for human lung mast cell migration.

Authors:  G Cruse; S M Duffy; C E Brightling; P Bradding
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

2.  Blunted IgE-mediated activation of mast cells in mice lacking the serum- and glucocorticoid-inducible kinase SGK3.

Authors:  Irina M Zemtsova; Nicole Heise; Henning Fröhlich; Syed M Qadri; Yuliya Kucherenko; Krishna M Boini; David Pearce; Ekaterina Shumilina; Florian Lang
Journal:  Am J Physiol Cell Physiol       Date:  2010-08-04       Impact factor: 4.249

Review 3.  Serum- and glucocorticoid-inducible kinase 1 in the regulation of renal and extrarenal potassium transport.

Authors:  Florian Lang; Volker Vallon
Journal:  Clin Exp Nephrol       Date:  2011-11-01       Impact factor: 2.801

4.  Sphingosine-1-phosphate can promote mast cell hyper-reactivity through regulation of contactin-4 expression.

Authors:  Ana Olivera; Yoshiaki Kitamura; Laurel D Wright; Maria L Allende; Weiping Chen; Tomomi Kaneko-Goto; Yoshihiro Yoshihara; Richard L Proia; Juan Rivera
Journal:  J Leukoc Biol       Date:  2013-07-31       Impact factor: 4.962

5.  Reciprocal modulation of anti-IgE induced histamine release from human mast cells by A₁ and A(2B) adenosine receptors.

Authors:  K H Yip; H Y A Lau; H Wise
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

6.  CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction.

Authors:  Giorgia Gri; Silvia Piconese; Barbara Frossi; Vanessa Manfroi; Sonia Merluzzi; Claudio Tripodo; Antonella Viola; Sandra Odom; Juan Rivera; Mario P Colombo; Carlo E Pucillo
Journal:  Immunity       Date:  2008-11-14       Impact factor: 31.745

Review 7.  Regulation of Ca2+ signaling with particular focus on mast cells.

Authors:  Hong-Tao Ma; Michael A Beaven
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

Review 8.  The K+ channels K(Ca)3.1 and K(v)1.3 as novel targets for asthma therapy.

Authors:  Peter Bradding; Heike Wulff
Journal:  Br J Pharmacol       Date:  2009-08       Impact factor: 8.739

9.  Systemic effects of ingested Lactobacillus rhamnosus: inhibition of mast cell membrane potassium (IKCa) current and degranulation.

Authors:  Paul Forsythe; Binxiang Wang; Ibrahim Khambati; Wolfgang A Kunze
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

10.  Adenosine closes the K+ channel KCa3.1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor.

Authors:  S Mark Duffy; Glenn Cruse; Christopher E Brightling; Peter Bradding
Journal:  Eur J Immunol       Date:  2007-06       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.